Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Eli Lilly’s ...

Severe or decompensated obstructive sleep apnoea syndrome (OSAS) was significantly associated with functional hypogonadism in men with severe obesity. Continuous positive airway pressure (CPAP) ...

The World Health Organization issued new guidelines Monday recommending the use of GLP-1 drugs for treating obesity. In the new guidelines, the United Nations health agency made two key ...

A new study published in the Journal of Lipid Research suggests that soybean oil, the most widely consumed cooking oil in the United States, may play a direct role in promoting obesity, and the effect ...

1 Department of Respiration, Children’s Hospital of Soochow University, Suzhou, China 2 Jinan Maternity and Child Care Hospital Affiliated to Shandong First Medical University, Jinan, China Objective: ...

José Miguel Soriano del Castillo does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant ...

President Trump announced a deal with Eli Lilly and Novo Nordisk to lower prices on hugely popular weight-loss drugs for Medicare, Medicaid and American patients who pay with their own money. By ...

For decades, the obesity rate among Americans trended inexorably higher, to a peak of 39.9 percent in 2022. But now, new data from Gallup’s National Health and Well-Being Index shows that something ...

As more Americans turn to weight loss drugs, the U.S. adult obesity rate is declining, according to new survey data from Gallup. The data published Tuesday showed the obesity rate among participants ...

Not long ago, obesity was popularly considered a disease of affluence — the product of excess and overindulgence. Today, obesity is increasingly recognized as a disease of poverty, rooted in ...

Objective: To investigate the clinical characteristics and risk factors of overlap syndrome (OVS) patients with metabolic syndrome (Mets) in middle-high altitude areas. Methods: A retrospective ...

Pfizer $4.9 billion cash acquisition of Metsera, a clinical-stage biotech focused on next-generation obesity drugs, is more than another high-profile deal in pharma’s dealmaking spree. It signals a ...